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ABSTRACT: Zinc sulﬁde (ZnS) nanoparticles (NPs) are
particularly interesting materials for their electronic and
luminescent properties. Unfortunately, their robust and stable
functionalization and stabilization, especially in aqueous
media, has represented a challenging and not yet completely
accomplished task. In this work, we report the synthesis of
colloidally stable, photoluminescent and biocompatible core−
polymer shell ZnS and ZnS:Tb NPs by employing a water-in-
oil miniemulsion (ME) process combined with surface
functionalization via catechol-bearing poly-2-methyl-2-oxazo-
line (PMOXA) of various molar masses. The strong binding
of catechol anchors to the metal cations of the ZnS surface, coupled with the high stability of PMOXA against chemical
degradation, enable the formation of suspensions presenting excellent colloidal stability. This feature, combined with the
assessed photoluminescence and biocompatibility, make these hybrid NPs suitable for optical bioimaging.
■ INTRODUCTION
The robust, steric stabilization of inorganic nanoparticles
(NPs) within aqueous and physiological media via an
appropriate chemical functionalization stands as a fundamental
requirement to enable their application in the biomedical ﬁeld.
Whereas in the cases of metallic and metal oxide NPs well-
established and reliable functionalization protocols have been
set,1 the development of eﬀective surface-derivatization
methods for metal sulﬁde-based analogues has not been
achieved so far by synthetic chemists, and, in particular, the
actual chemical nature of the functionalized surface has not
been thoroughly characterized.2 Furthermore, reports retrieved
in the literature fail to convincingly demonstrate the stable
functionalization of metal sulﬁdes.3,4
Zinc sulﬁde (ZnS) has been especially investigated, because
of its appealing electronic properties, i.e., a wide band gap (3.7
eV) and a high exciton binding energy (40 meV).5,6 These
features make ZnS one of the most appealing semiconducting
materials for the fabrication of electroluminescent devices,
allowing a direct conversion of electric energy into visible light,
without generating heat or requiring chemical or mechanical
triggers.7 In addition, ZnS can be accessibly doped by multiple
ions (multiplexing), making it a suitable starting material for
the development of optical and optoelectronic devices.7
For all these reasons, combined with their nontoxicity and
intrinsic photoluminescence, ZnS NPs are envisioned as high-
performing and biocompatible bioimaging probes.4,8
Despite their appealing properties, a comprehensive and
unambiguous characterization of the surface composition of
ZnS NPs (following the diverse synthetic pathways to obtain
them) has not been provided so far,9−11 thereby hampering the
identiﬁcation of an eﬀective functionalization protocol and
making the choice of a robust anchoring chemistry a
challenging task. Although, in several experimental and
theoretical studies, it has been proposed that the ZnS surface
could feature either oxidized species (SO4, SO3, ZnO) or
reduced (SH, ZnOH) moieties,12 no unequivocal proof of the
chemical nature of these surfaces has been presented yet.
Hence, coherent evidence of the selective ZnS surface
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derivatization by adsorbates presenting appropriate organic
anchors still remains a partially unaccomplished issue.
Recently, the incorporation of ZnS:Mn NPs into a polymeric
matrix including poly(acrylic acid) (PAA) and poly(methyl
methacrylate) (PMMA) to convey luminescent properties to
plastics was investigated, although no speciﬁc functions of the
polymers were demonstrated to enhance the interactions with
the NPs.13,14 Alternatively, semiconductor nanocrystals
(entirely or partially constituted by sulﬁdes15,16) were
successfully incorporated into polymeric matrices14,17 or
derivatized with oleic acid and hexadecyl-trimethylammonium
bromide18 to permit their dispersion in organic phases. Also in
these cases, no detailed description of the characteristics of the
coated surface and proofs of the eﬀective functionalization
were provided.
In several other reports,3,19,20 the functionalization of ZnS
NPs was achieved by means of adsorbates presenting cysteine
functions, suggesting the formation of S−S linkages with the
sulfur present on the NP surface. Remarkably, the stability of
the obtained suspensions was not addressed. More recent
reports21,22 focused on ZnS:Mn quantum dots coated with
pyridine or hypromellose, where these capping agents were
loaded during the ZnS:Mn quantum dots synthesis and acted
as both stabilizing and growth-inhibitor agents. The successful
surface derivatization was veriﬁed by Fourier transform
infrared (FT-IR) spectroscopy.
Motivated by the need to ﬁnd suitable and eﬀective
adsorbates for the stable functionalization and dispersion of
ZnS NPs in aqueous media, we especially focused on the
development of poly(2-methyl-2-oxazoline) (PMOXA)-based
ligands. The application of PMOXA for NPs stabilization
represents a technologically relevant strategy for further
biomedical applications,23−34 as PMOXA proved to be more
chemically stable toward oxidation and enzymatic degradation,
compared to the most applied poly(ethylene glycol) (PEG)
derivatives, yet maintaining good biocompatibility and endow-
ing the NPs with stealth properties.35−37 In particular, we ﬁrst
synthesized ZnS and Tb-doped ZnS (ZnS:Tb) NPs by a
miniemulsion (ME) approach,38 obtaining discrete aggregates
of NPs with typical crystallite dimensions of 6 nm. The
structure and the surface composition of the NPs were
characterized by a combination of X-ray photoelectron
spectroscopy (XPS), powder X-ray diﬀraction (XRD), and
transmission electron microscopy−selected area electron
diﬀraction (TEM-SAED), which consistently indicated the
presence of crystalline sphalerite ZnS. Later, PMOXA bearing
substituted catechol end-groups were anchored to the NPs.
Similar functions were previously shown to enable the
functionalization of diﬀerent metal oxide NPs, including
Fe3O4 and ZnO, through the formation of a stable ﬁve-
membered coordination ring with the metal centers exposed at
the NPs surface.35,39−41 In the present study, we demonstrate
that nitrodopamine (ND) and bromo-substituted dopamine
(BrD) can eﬀectively bind to the ZnS surface, forming a
densely grafted polymer shell. The substitution of catechol-
based anchors with electron-withdrawing groups, such as NO2
and Br, decreases the pKa of the hydroxyl moieties. This
provides a stronger binding to the metal surface, when
compared to unmodiﬁed catechols, and simultaneously
prevents the catechol self-polymerization/oxidation reac-
tions.40,42 These features are especially remarkable for the
functionalization of ZnS NPs. On the one hand, the lower
acidity of the Zn2+ in ZnS, with respect to ZnO, can be
partially compensated by the enhanced reactivity of the
substituted catechols, on the other hand, the stronger aﬃnity
of the ligands toward the ZnS surface inhibits its oxidation or
passivation.
Relevantly, ND and BrD anchors feature a similar aﬃnity
toward the inorganic surface; however, they present diﬀerent
optical properties, with the former adsorbing in the near UV
and thus presenting some limitations when bioimaging
applications or staining procedures are required.
Investigating a selection of PMOXAND and PMOXABrD
for the functionalization of ZnS and ZnS:Tb NPs, the molar
mass of the ligand emerges as a key parameter for ensuring the
long-term steric stabilization of the colloids against aggregation
and Ostwald ripening in physiological media.
Finally, the luminescent properties of Tb-doped NPs were
assessed and the biocompatibility of the fabricated ZnS-
PMOXAs and ZnS:Tb-PMOXAs hybrids was tested on human
lung adenocarcinoma (A549 cell line) cells, showing absence
of cytotoxicity, and disclosing exciting perspectives for the
application of these NPs as optical bioimaging probes.
■ EXPERIMENTAL SECTION
Materials. For the preparation of ZnS NPs, zinc nitrate
hexahydrate (Zn(NO3)2·6H2O) and sodium sulﬁde (Na2S) were
obtained from Sigma−Aldrich, cyclohexane (C6H12) was purchased
from Alfa−Aesar. The polyglycerol polyricinoleate (PGPR) was
obtained from Palsgaard. All chemicals were used without further
puriﬁcation. For the synthesis of PMOXA ligands, all the chemicals
were purchased from Aldrich. 2-Methyl-2-oxazoline (MOXA) and
methyl triﬂate (MeOTf) were distilled over KOH and CaH2,
respectively, before use.
Preparation of ZnS Nanoparticles (NPs). Two identical
mixtures, A and B, were prepared by dispersing PGPR (0.16 g) in
cyclohexane (16 g); then, 3 g of an aqueous 0.5 M solution of
Zn(NO3)3 (0.8 mmol, 2 mL) were added to mixture A and
mechanical stirring allowed us to yield emulsion A′. Emulsion B′ was
obtained by adding 3 g of an aqueous 1 M solution of Na2S (2.8
mmol, 2.8 mL) to mixture B and subsequent mechanical stirring.
Corresponding miniemulsions A and B were obtained by ultra-
sonication performed at the same time (3 min) and amplitude, by
using a homogenizer (Sartorius Stedim LabsonicP) equipped with a
titanium tip of 3 mm in diameter, working at an amplitude of 70%
(corresponding to an acoustical power of 322 W cm−2). A and B were
mixed together and sonicated for the same time and at the same
amplitude. The resulting white miniemulsion was mechanically stirred
at room temperature for 4 h. Then, the powder product was separated
by centrifugation (10 000 rpm, 10 min) and washed with acetone and
deionized water several times. The white solid was dried in an oven at
80 °C for 4 h. In the case of the Tb-doped ZnS NPs, a similar
procedure was followed, adding Tb(NO3)3 to solution A (1:20 w/
wwith respect to Zn(NO3)) (see Figure S1 in the Supporting
Information).
Nitrodopamine Hemisulfate and Tribromodopamine Hy-
drobromide. Nitrodopamine hemisulfate was synthesized according
to the literature.43 The synthesis of tribromodopamine hydrobromide
was performed according to previous reports.44,45
PMOXAND and PMOXABrD. COOH-terminated PMOXAs were
synthesized according to a modiﬁcation of a previously reported
procedure.30 MOXA (10, 20, 40, and 70 equiv, depending on DP)
was dissolved in 30 mL of dry acetonitrile. MeOTf (1 equiv) was
added at 0 °C to the monomer mixture. The polymerization was
performed at 70 °C. After 24 h, ethylisonipecotate (3 equiv, distilled
under vacuum) was added at room temperature (RT) and it was
allowed to react for 48 h. The solution was dried under reduced
pressure and the solid was dissolved in Milli-Q water, puriﬁed via
dialysis, and ﬁnally lyophilized. Hydrolysis of ethyl-ester function at
PMOXA chain ends was performed in NaOH aqueous solution (pH
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13) for 24 h. Puriﬁcation and drying were performed via dialysis and
freeze-drying. In order to obtain the catechol-bearing polymers, the
polymer was dissolved in anhydrous dimethyl formamide (DMF) and
two DMF solutions of N-hydoxysuccinimide (NHS) and N,N'-
dicyclohexylcarbodiimide (DCC) were added separately to the
polymer. After 24 h of stirring at RT, the catechols (ND or BrD)
and N-methylmorpholine were added at 0 °C for additional 24 h. The
puriﬁcation ﬁrst involved the ﬁltration of the side-product
dicyclohexylurea and then dialysis against water. The product was
ﬁnally freeze-dried (see Figure S2 in the Supporting Information).
Size exclusion chromatography (SEC) and 1H nuclear magnetic
resonanace (1HNMR) spectroscopy were used to characterize
PMOXAND and PMOXABrD ligands (see Table S1 and Figures
S3−S7 in the Supporting Information).
ZnS NPs Functionalization. A DMF solution of the polymer was
added to a suspension of ZnS in DMF (ZnS:polymer weight ratio =
1:50). The mixture was left to react overnight at RT. Then, the
solution was dried and the solid suspended in Milli-Q water, puriﬁed
by dialysis (membranes cutoﬀ: 25 kDa), and ﬁnally freeze-dried.
XPS. Powder samples were investigated by XPS using a Perkin−
Elmer φ 5600ci instrument with standard Al Kα radiation (1486.6
eV) operating at 350 W. The working pressure was lower than 5 ×
10−8 Pa. The calibration was based on the binding energy (BE) of the
Au 4f7/2 line at 83.9 eV, with respect to the Fermi level. The standard
deviation for the BE values was 0.15 eV. Reported BEs were corrected
for charging eﬀects, and the BE value of 284.6 eV was assigned to the
C 1s line of carbon. Survey scans were obtained in the 0−1350 eV
range (pass energy = 187.5 eV, 1.0 eV step−1, 25 ms step−1). Detailed
scans (pass energy = 29.35 eV, 0.1 eV step−1, 50−150 ms step−1) were
recorded for the O 1s, C 1s, Zn 2p, ZnLMM, S 2p, and the Tb 3d
regions. The atomic composition, after a Shirley-type background
subtraction, was evaluated using sensitivity factors supplied by
Perkin−Elmer. Peak assignment was performed according to literature
data.46−48
X-ray Diﬀraction (XRD). The XRD patterns on the ZnS NPs
were collected with a Bruker D8 Avance diﬀractometer that was
equipped with a Göbel mirror by using the Cu Kα radiation in the 2θ
range of 10°−70°. The angular accuracy was 0.001°, and the angular
resolution was better than 0.01°.
Thermogravimetric Analysis (TGA). TGA measurements on the
functionalized NPs were performed with a thermobalance LabSys
Setarm SDT 2960 (TA Instruments) in the temperature range of 20−
800 °C in air with a dynamic heating rate of 10 °C min−1.
Transmission Electron Microscopy (TEM). TEM analysis was
performed with a Philips CM12 microscope operating at 120 keV and
equipped with an energy-dispersive X-ray spectroscopy (EDXS)
system, which allowed for localized chemical analyses. For each
sample, both images and SAED patterns were collected to investigate
the morphology and dimensions of ZnS NPs, and their local chemical
composition. For the identiﬁcation of the phases and assignment of
the relevant peaks, Process Diﬀraction software was used.
Atomic Force Microscopy (AFM). A Bruker Dimension Icon
atomic force microscope was used in tapping mode, employing a SiN
cantilever with a resonance frequency of 300 kHz, and the spring
constant was 22.9 N m−1.
Fourier Transform Infrared (FT-IR) Analysis. Experiments were
performed on a NEXUS 870 FT-IR (Nicolet), operating in the
transmission range of 400−4000 cm−1, collecting 64 scans with a
spectral resolution of 4 cm−1. The measurements were recorded by
dispersing the powders in anhydrous KBr pellets.
Size Exclusion Chromatography (SEC). Number- and weight-
average absolute molecular weights (Mn and Mw, respectively) of
PMOXA ligand precursors were determined by SEC. An Agilent 1100
unit was used; it was equipped with two PFG linear M columns (PSS)
connected in series with an Agilent 1100 VWD/UV detector operated
at 290 nm, a DAWN HELEOS 8 multiangle laser light scattering
(MALS) detector (Wyatt Technology Europe), followed by an
Optilab T-rEX RI detector from Wyatt. Samples were eluted in
hexaﬂuoroisopropanol (HFIP) with 0.02 M K-TFAc at 1 mL/min at
room temperature. Absolute molecular weights were evaluated with
Wyatt ASTRA software and dn/dc values based on our analytical
setup (dn/dc (PMOXA) = 0.2498 mL/g).
Nuclear Magnetic Resonance (NMR). 1H NMR spectra were
collected on Bruker Ultrashield MHz 300 or 500 spectrometers in
D2O.
Dynamic Light Scattering (DLS). Dynamic light scattering
(DLS) analysis on the suspensions were performed in water and PBS,
using a Malvern Zetasizer NanoS, at a temperature of 20 °C.
Fluorescence Spectroscopy. Luminescence measurements were
performed with a Horiba FluoroMax-P spectroﬂuorometer with a
phosphorimeter accessory. The accuracy of the emission spectra was
0.5 nm.
Cell Culture. The human A549 cells (lung adenocarcinoma) were
purchased from American Type Culture Collection (ATCC n. CCL-
185) and cultured in Ham’s F12-K Nutrient Mixture (Invitrogen Life
Technologies, Carlsbad, CA, USA) supplemented with 10% heat
inactivated fetal bovine serum (FBS, BIOCHROM, Berlin, Germany),
38 units/mL streptomycin, and 100 units/mL penicillin G, in T75
cm2 ﬂasks (FALCON). Cells were kept at 37 °C in a humidiﬁed
atmosphere of 95% air and 5% CO2, and maintained in exponential
and asynchronous phase of growth by repeated trypsinization and
reseeding prior to reaching subconﬂuency. The cells were seeded and
maintained for 24 h in complete culture medium before starting the
NP treatment; then, the cells were incubated with medium (3% FBS)
in which the NPs stock suspensions were freshly diluted. The
percentage of serum (3%) supplemented represents the lower
percentage suitable for maintaining the cells up to 72 h without
suﬀering, in accordance with our previous observations.49,50 Cells
were incubated for 24 h with increasing concentrations of NPs (0.01−
0.1 mg/mL) and then plated for clonogenic assay. Control cells
underwent the same steps of treated cells, except for NPs exposure.
For cytotoxicity analysis, the NPs stock solutions were diluted with
ultrapure water (1 mg/mL) and the NPs suspensions were sterilized
by ﬁltration with 0.22 μm.
Clonogenic Assay. Cells (0.15 × 106/well) were seeded in 24-
well plates and 24 h later were subjected to NPs treatment, harvested
by trypsinization, and counted by Trypan Blue dye exclusion. Five
hundred (500) viable cells were plated in 6 cm culture dishes in
culture medium supplemented with 10% FBS and after 7−10 days at
37 °C, the colonies were counted after staining with 0.4% crystal
violet and counted. Only colonies containing more than 50 cells were
scored as survivors to determine the cloning eﬃciency (CE), i.e., the
proportion of cells that attach and grow to the number of cells
originally plated, expressed as a percentage. Cell survival was
calculated as percentage of CE of NP-treated cells over that of
untreated control cells.
Cellular Internalization of NPs. A549 cells (105) were seeded in
35 mm culture dishes and, after 24 h, were treated with NPs for 24 h.
The cells seeded on a cover slip were primary ﬁxed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buﬀer at pH 7.4 for 1 h at
room temperature and then washed thrice with cacodylate buﬀer (10
min each wash). The samples were post-ﬁxed with a mixture of 1%
osmium tetroxide and 1% potassium ferrocyanide in 0.1 M sodium
cacodylate buﬀer for 1 h at 4 °C, dehydrated in ethanol from 25% to
100% (thrice) for 10 min each step, and ﬁnally included in epoxy
resin. The samples were sectioned with an Ultrotome V ultra-
microtome (LKB instruments, Victoria, TX, USA). Thin sections
(80−100 nm) were counterstained with uranyl acetate and lead
citrate and then observed with a Tecnai G2 transmission electron
microscope (FEI Company, Hillsboro, OR, USA) operating at 100
kV. Images were captured with a Veleta (Olympus Soft Imaging
System) digital camera.
■ RESULTS AND DISCUSSION
Synthesis and Characterization of ZnS NPs. ZnS and
ZnS:Tb NPs were synthesized following an inverse (water-in-
oil, w-o) ME route, which aﬀorded good control and
reproducibility over the NP size.38 A ME is a three-component
metastable system composed by small droplets stabilized with
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a surfactant in an immiscible phase.51−54 These systems have
already been exploited for the crystallization of inorganic
colloids.46−55 Each droplet works as an independent nano-
reactor in which the precipitation and the crystallization of the
product occur already at RT.38,56−58 Speciﬁcally, the
preparation of ZnS NPs was achieved by mixing two aqueous
solutions of Zn(NO3)2 and Na2S, dispersed in cyclohexane,
and using polyglycerol polyricinoleate (PGPR) as an emulsiﬁer
(see Scheme 1). This surfactant allowed us to achieve a
hydrophilic/lipophilic balance (HLB) value in the range of 1−
5, which is considered the optimum for the stabilization of w-o
ME.58
The crystalline structure of the synthesized NPs was veriﬁed
by XRD. The typical diﬀraction pattern displayed in Figure 1
evidences the formation of crystalline ZnS as sphalerite
polymorph already at RT (PDF N. 00-001-1281, 2θ = 28.55,
32.95, 47.55, 56.45), without the need of further thermal
treatment.38 An average crystallite size of 6 nm was determined
by applying the Scherrer equation.59
The chemical composition of the surface of the NPs was
subsequently analyzed by XPS (Figure 2). The survey
spectrum, covering the entire BE range (0−1350 eV), revealed
all the species of interest (S, Zn, O, C) (Figure 2a). The peaks
corresponding to carbon and oxygen were mainly due to the
presence of PGPR surfactant physisorbed on the surface of the
NPs, as well as to adventitious contamination. XPS
investigation was deepened by recording more-detailed spectra
within narrower BE regions. From the Zn 2p and S 2p XPS
regions (see Figures 2b and 2c), it was possible to determine
the binding energies and atomic concentrations (percentage)
of the species on the exposed surface of the NPs.
In order to rule out the presence of a ZnSO4 passivating
layer on the NPs, the oxidation state and chemical environ-
ment of sulfur and zinc were evaluated by ﬁtting the S 2p and
Zn 2p signals. The S 2p peak should be a doublet but, given
the low resolution of the spectrometer (0.15 eV) and the low
value of the spin−orbit splitting (1.18 eV),60 this could not be
evidenced. This signal was ﬁtted with a single interpolation
peak, showing that all the S-containing species at the surface of
the NPs have the same chemical environment. The BE for the
transition corresponded to 161.5 eV, which is compatible with
S in ZnS.61 The presence of ZnSO4 could be excluded, as the
typical binding energies for this compound would be expected
in the range of 169.2−169.8 eV for S 2p60,61 and at ∼1023 eV
for Zn 2p3/2. Further evidence for the presence of ZnS at the
Scheme 1. Preparation of ZnS and ZnS:Tb NPs via Miniemulsion (ME)a
aTwo aqueous solutions of metal and sulﬁde precursors were dispersed in cyclohexane (panel (a)), using polyglycerol polyricinoleate (PGPR) as an
emulsiﬁer (panel (b)). The formation of the NPs (panel (c)) was followed by the ligand exchange between PGPR and PMOXA ligands, to yield
the desired ZnS-PMOXA and ZnS:Tb-PMOXAs core−polymer shell NPs (panel (d)).
Figure 1. XRD pattern of ZnS NPs.
Figure 2. (a) XPS survey spectrum of ZnS NPs; (b, c) detailed
spectra of the Zn 2p (panel (b)) and S 2p region (panel (c)).
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surface of NPs was the measured BE for Zn, which was
compatible with those reported for ZnS.60 Finally, the
quantitative analysis conﬁrmed an atomic ratio Zn:S of 1:1,
which is consistent with the stoichiometry of ZnS.
The absence of metal oxide species on the surface of NPs
was further corroborated via SAED, which was performed on
TEM micrographs (see Figures 3a and 3b). As shown in Figure
3a, ZnS NPs present an average diameter of ∼10 nm, in good
agreement with the value obtained by the Scherrer equation.
Remarkably, the diﬀraction pattern associated with the SAED
analysis was indexed as ZnS and no presence of ZnO could be
highlighted (Figure 3b). Hence, the combination of XPS,
XRD, and SAED data unambiguously demonstrated that the
inverse ME process yielded NPs exclusively featuring ZnS at
their exposed surface.
Synthesis and Characterization of ZnS-PMOXA NPs.
PMOXA ligands with diﬀerent molar masses and presenting
either ND or BrD chain ends were applied as surface modiﬁers
and stabilizers for ZnS NPs. Four diﬀerent carboxylic acid-
terminated PMOXAs, presenting average molar masses of
1500, 2300, 4500, and 8000 Da, were synthesized correspond-
ing to average degrees of polymerization (DP) of 18, 27, 50
and 90, respectively (a detailed characterization of PMOXA
species is reported in the Supporting Information). The
diﬀerent polymers were subsequently coupled to ND hemi-
sulfate or BrD hydrobromide salts via NHS/DCC chemistry
(see the Experimental Section and Figures S2−S8 in the
Supporting Information for details), ﬁnally yielding eight
diﬀerent ligands, PMOXA(18)ND, PMOXA(27)ND,
PMOXA(50)ND, PMOXA(90)ND, PMOXA(18)BrD,
PMOXA(27)BrD, PMOXA(50)BrD, and PMOXA(90)BrD.
The two types of anchors used in this study, ND and BrD,
feature diﬀerent light adsorption properties (see Figure S9 in
the Supporting Information), which make them interesting
compounds for the designing of hybrid materials for optical
bioimaging.
ZnS and ZnS:Tb NPs were functionalized with the diﬀerent
PMOXA(x)ND and PMOXA(x)BrD by direct ligand ex-
change, suspending the PGPR-stabilized NPs in DMF in the
presence of a 50-fold weight excess of each PMOXA ligand.
After puriﬁcation via dialysis, ZnS-PMOXA(x)ND and ZnS-
PMOXA(x)BrD were collected.
Because of the stronger aﬃnity of the catechol anchors for
the ZnS surface compared to the surfactants physisorbed
during the ME synthesis, a nearly quantitative functionalization
was achieved. As exemplarily shown in Figure 4, the FT-IR
spectra of ZnS-PMOXA(90)ND and ZnS-PMOXA(50)BrD
NPs suspensions displayed the typical signals ascribable to the
PMOXA ligand at 1637 cm−1 (amide CO stretching) and
between 1480 and 1400 cm−1 (polymeric CH bending and
aromatic CC stretching). Simultaneously, the signals
characteristic of the PGPR surfactant (carbonyl vibrations at
1731 cm−1 and ether stretching at 1200 cm−1) disappeared,
indicating the successful and quantitative ligand exchange.
The functionalization of ZnS NPs by the diﬀerent PMOXA
ligands was additionally evaluated by thermogravimetric
analysis (TGA) (Figure S10 in the Supporting Information).
Speciﬁcally, TGA measurements were performed to estimate
the amount of ligand bound to the NPs after ligand exchange
and puriﬁcation by dialysis. The weight fraction of bound
ligand obtained by TGA was compared for each sample with
the initial PMOXA weight fraction introduced during the
ligand exchange (both quantities are expressed, in terms of
weight percent, in Table 1). The results showed that all the
diﬀerent PMOXA ligands quantitatively bound the surface of
ZnS NPs until surface saturation was achieved, conﬁrming the
eﬀective and quantitative functionalization of ZnS NPs by
catechol-substituted PMOXAs. In all the cases, the PMOX-
A:ZnS weight ratio used for the ligand exchange was 50:1,
Figure 3. (a) TEM micrograph and SAED pattern of pristine ZnS
NPs. Scale bar = 50 nm. (b) Integrated diﬀraction pattern of ZnS NPs
as synthesized. The red trace is the experimental average intensity
over circles, the blue and green set of signals are namely the tabulated
ZnS (PDF No. 01-0792) and ZnO (PDF No. 79-2205). (c) Atomic
force microscopy (AFM) tapping-mode micrograph highlighting
aggregates of pristine ZnS NPs (the scale bar corresponds to 1 μm).
Figure 4. (a) FT-IR spectra of PGPR surfactant (black trace), PGPR-
stabilized ZnS NPs (red trace), PMOXA(90)ND (blue trace), and
ZnS-PMOXA(90)ND (green trace). (b) FT-IR spectra of PGPR
surfactant (black trace), PGPR-stabilized ZnS NPs (red trace),
PMOXA(50)BrD (blue trace), and ZnS-PMOXA(50)BrD (green
trace).
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corresponding to 98% PMOXA. The amount of polymer
ligand applied thus exceeded NPs surface saturation, which was
reached at PMOXA:ZnS weight ratios ranging from 90% to
97%.
The amount of bound polymer measured by TGA could be
used to estimate the surface density of PMOXA ligands, which
was always included between 2 chains nm−2 and 6 chains
nm−2, in accordance to the values previously reported for
chemically similar polymer shells on metal oxide NPs.36
The stability of ZnS-PMOXA NPs dispersions was
subsequently monitored in water and in PBS at pH 7.4 by
DLS (see Table 2), recording the average hydrodynamic
diameter (HD) of the dispersed NPs over a period of 7 days
(see Figure S11 in the Supporting Information).
PMOXA ligands with relatively low DP (PMOXA(18) and
PMOXA(27)) were less eﬀective in stabilizing the NPs,
particularly in PBS, where the formation of large aggregates
was recorded.
In contrast, the longer PMOXA(50) and PMOXA(90)
provided stable suspensions with average HD values ranging
between 145 nm and 165 nm. Especially in PBS, where the
presence of electrolytes reduces the electrostatic repulsions
between NPs and thins the electrical double layer, high-molar-
mass PMOXA ligands eﬃciently prevented aggregation and
ﬂocculation of the NPs. Moreover, it is important to emphasize
that aqueous dispersions of Zn NPs functionalized with long
PMOXA ligands remained stable for up to 9 months of
incubation (see Table S2 in the Supporting Information).
Atomic force microscopy (AFM) tapping-mode micrographs
qualitatively conﬁrmed the results of DLS. As reported in
Figure 5, the shorter PMOXA(18)ND and PMOXA(18)BrD
were not capable of providing singly dispersed NPs (see
Figures 5a and 5e, for ZnS-PMOXA(18)ND and ZnS-
PMOXA(18)BrD, respectively) from the native ZnS aggre-
gates (Figure 3c), while NP clusters of variable size were
found. In contrast, PMOXA ligands of higher DP produced
ﬁne dispersions of single NPs with average size in the range
50−100 nm (Figures 5b−d and 5f−h).
The diﬀerent values of NP size provided by DLS, TEM, and
AFM were probably due to the intrinsic diﬀerences in the
physical quantities measured by these methods. Moreover, the
increase in diameter recorded both by DLS, TEM, and AFM,
compared to the crystallite size derived from XRD analysis, was
Table 1. TGA of ZnS-PMOXAs NPs, Initial Weight
Percentage of PMOXA Added during Ligand Exchange, and
Weight Percentage of Bound PMOXA
PMOXA Amount (wt %)
sample initial bound
ZnS-PMOXA(18)BrD 98 90
ZnS-PMOXA(27)BrD 98 92
ZnS-PMOXA(50)BrD 98 93
ZnS-PMOXA(90)BrD 98 97
ZnS-PMOXA(18)ND 98 92
ZnS-PMOXA(27)ND 98 95
ZnS-PMOXA(50)ND 98 90
ZnS-PMOXA(90)ND 98 92
Table 2. Average Hydrodynamic Diameters (HD) of ZnS-
PMOXA NPs (in water and PBS), Determined by DLS
Analysis
Average HD - Intensity Distributiona (nm)
sample in water in PBS
ZnS-PMOXA(18)ND 200 ± 110 (100%) 298 ± 131 (70%)
191 ± 170 (30%)
ZnS-PMOXA(18)BrD 146 ± 4 (99%) 570 ± 213 (100%)
ZnS-PMOXA(27)ND 139 ± 18 (60%) 216 ± 40 (65%)
3.5 ± 0.2 (36%) 3.2 ± 0.6 (25%)
ZnS-PMOXA(27)BrD 131 ± 6 (100%) 132 ± 5 (100%)
ZnS-PMOXA(50)ND 162 ± 6 (100%) 159 ± 3 (100%)
ZnS-PMOXA(50)BrD 145 ± 4 (100%) 145 ± 4 (100%)
ZnS-PMOXA(90)ND 152 ± 4 (100%) 146 ± 4 (99%)
ZnS-PMOXA(90)BrD 155 ± 6 (100%) 153 ± 7 (100%)
aArea percentages are reported in brackets.
Figure 5. AFM tapping-mode micrographs showing ZnS NPs
functionalized with (a−d) PMOXA(x)ND ligands and (e−h)
PMOXA(x)BrD ligands: (a) ZnS:PMOXA(18)ND, (b)
ZnS :PMOXA(27)ND, (c) ZnS :PMOXA(50)ND, (d)
ZnS :PMOXA(90)ND, (e) ZnS :PMOXA(18)BrD , ( f )
ZnS:PMOXA(27)BrD, (g) ZnS:PMOXA(50)BrD, and (h)
ZnS:PMOXA(90)BrD.
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ascribed to the steric hindrance provided by the dense
PMOXA shells and their highly hydrated character.
The TEM-SAED micrographs reported in Figure 6 addi-
tionally highlighted the formation of an organic shell after
functionalization of the pristine ZnS NPs with PMOXAND
and PMOXABrD. The analysis of the corresponding
diﬀraction patterns associated with the SAED analysis (insets
in Figure 6a−d) further excluded the presence of ZnO on the
NPs, conﬁrming the presence of sulﬁdes on the surface of the
functionalized NPs.
Synthesis and Characterization of Tb-Doped ZnS-
PMOXA NPs. In order to test their potential application as
bioimaging probes, ZnS-PMOXA NPs were doped with Tb3+
as a luminescent component. Namely, ZnS:Tb NPs were
synthesized by adding Tb(NO3)3 in a 1:20 Tb:Zn atomic ratio
to the ME containing the Zn precursor.22 ZnS:Tb NPs were
functionalized in a similar way as already described for the ZnS
NPs. XRD analyses (data not shown) proved the crystallization
of sphalerite, irrespective of the presence of the inorganic
dopant.
Phosphorescence emission spectroscopy conﬁrmed the
presence of Tb ions trapped in the ZnS nanostructures (see
Figure 7a), through the strong, characteristic emission bands
centered at 545, 594, and 625 nm.62,63
After ligand exchange, both ZnS:Tb-PMOXA(x)ND and
ZnS:Tb-PMOXA(x)BrD showed a relevant decrease in
phosphorescence intensity, with respect to the bare ZnS-Tb
(Figure 7b), presumably due to absorption of the excitation
wavelength by the ligands (Figure 7c). Nevertheless, this did
not translate in a complete quenching of the signals,
conﬁrming that the NPs could be applied as imaging probes,
even after PMOXA functionalization.
Cytotoxicity of ZnS-PMOXA NPs. In order to test the
cytotoxicity and biocompatibility of the fabricated core−
PMOXA shell NPs, human A549 cells were incubated for 24h
in culture medium containing increasing concentrations of
ZnS:Tb-PMOXA(x)ND and ZnS:Tb-PMOXA(x)BrD. The
cytotoxicity of NPs was evaluated by clonogenic assay, which
measures the ability of single cells to form colonies. This assay
is based on the retention of proliferation ability by only viable
and healthy cells. Therefore, it is a very sensitive test to assess
the potential toxicity of NPs, with respect to common
colorimetric assays, which, instead, are based on the detection
of the cellular enzymatic activities.57 The results showed that
clonogenic cell survival is unaﬀected by incubation in ZnS:Tb-
PMOXA NPs, highlighting that these are noncytotoxic at all of
the concentrations tested (see Figure 8).
In order to evaluate whether the NPs were eﬃciently
internalized by the cells, the intracellular localization of
ZnS:Tb-PMOXA(x)ND and ZnS:Tb-PMOXA(x)BrD NPs
was analyzed by TEM. From the micrographs shown in Figure
9, the NPs were internalized by A549, and, even though they
Figure 6. TEM micrographs and SAED pattern obtained from
suspension of (a) ZnS-PMOXA(90)ND, (b) ZnS-PMOXA(90)BrD,
(c) ZnS-PMOXA(27)BrD, and (d) ZnS-PMOXA(27)ND. All scale
bars correspond to 100 nm.
Figure 7. (a) Phosphorescence emission spectrum of ZnS:Tb, λex = 487 nm. (b) Phosphorescence emission spectra of ZnS:Tb functionalized with
three diﬀerent PMOXA-based ligands: ZnS:Tb-PMOXA(50)ND (black trace), ZnS:Tb-PMOXA(90)ND (green trace), and ZnS:Tb-
PMOXA(50)BrD (red trace). (c) Absorption spectra of ZnS:Tb-PMOXA(50)ND (red trace) and ZnS:Tb-PMOXA(27)BrD (black trace) in
the visible wavelength range. The increased absorbance for ZnS:Tb-PMOXA(50)ND is ascribable to ND (dashed trace), while BrD does not
absorb in the visible spectrum.
Figure 8. Cytotoxicity in human A549 cells. ZnS:Tb-PMOXA(x)ND
and ZnS:Tb-PMOXA(x)Br. Cell survival was calculated as a
percentage of cloning eﬃciency of NPs-treated cells over that of
untreated control cells. Data are mean ± SD from three independent
experiments.
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accumulated in particular cell areas, they still maintained their
individuality and did not aggregate.
■ CONCLUSIONS
In this work, we reported the successful preparation of ZnS
and ZnS:Tb NPs via ME process and their subsequent, robust
stabilization using cathecol-bearing PMOXA ligands of diﬀer-
ent molar masses. The inorganic NPs could be obtained as
pure and highly crystalline compounds at room temperature.
The combination of XRD, XPS, and TEM-SAED results
allowed us to rule out the presence of oxide and sulfate
passivation layers on the ZnS NPs. High-molar-mass PMOXA-
based ligands ensured an eﬃcient long-term stability of ZnS
NP within water and PBS suspensions.. ZnS:Tb-PMOXAs
were also proven to emit in the visible region of the spectrum
and were tested in vitro, showing no detectable cytotoxicity. All
these properties enable the application of these core−polymer
shell NPs as novel inorganic labels for optical bioimaging.
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(46) Muñoz-Espí, R.; Weiss, C. K.; Landfester, K. Inorganic
Nanoparticles Prepared in Miniemulsion. Curr. Opin. Colloid Interface
Sci. 2012, 17, 212−224.
(47) Muñoz-Espí, R.; Mastai, Y.; Gross, S.; Landfester, K. Colloidal
Systems for Crystallization Processes from Liquid Phase. CrystEng-
Comm 2013, 15, 2175.
(48) Harmer, S. L.; Goncharova, L. V.; Kolarova, R.; Lennard, W.
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